These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 10362794

  • 1. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [Abstract] [Full Text] [Related]

  • 2. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068
    [Abstract] [Full Text] [Related]

  • 3. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 01; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 01; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 5. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
    Frost SJ, Simpson DJ, Farrell WE.
    Mol Cell Endocrinol; 2001 May 15; 176(1-2):29-37. PubMed ID: 11369440
    [Abstract] [Full Text] [Related]

  • 6. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
    Factor V, Oliver AL, Panta GR, Thorgeirsson SS, Sonenshein GE, Arsura M.
    Hepatology; 2001 Jul 15; 34(1):32-41. PubMed ID: 11431731
    [Abstract] [Full Text] [Related]

  • 7. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 8. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF, Factor VM, Loi R, Thorgeirsson SS.
    Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770
    [Abstract] [Full Text] [Related]

  • 9. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM, Kao CY, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1997 Jun 01; 57(11):2089-95. PubMed ID: 9187100
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 11. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L, Terradillos O, Calvo L, Costabile B, Cicchini C, Della Rocca C, Lozupone F, Piacentini M, Buendia MA, Tripodi M.
    Oncogene; 2002 Feb 21; 21(9):1335-45. PubMed ID: 11857077
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.
    Kleeff J, Korc M.
    J Biol Chem; 1998 Mar 27; 273(13):7495-500. PubMed ID: 9516449
    [Abstract] [Full Text] [Related]

  • 13. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
    Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS.
    Carcinogenesis; 2004 Jun 27; 25(6):901-8. PubMed ID: 14742323
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
    Sanders S, Thorgeirsson SS.
    Mol Carcinog; 2000 Jul 27; 28(3):168-73. PubMed ID: 10942533
    [Abstract] [Full Text] [Related]

  • 19. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B).
    Feng XH, Liang YY, Liang M, Zhai W, Lin X.
    Mol Cell; 2002 Jan 27; 9(1):133-43. PubMed ID: 11804592
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid up-regulates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells.
    Li Z, Chen Y, Cao D, Wang Y, Chen G, Zhang S, Lu J.
    Endocrinology; 2006 Nov 27; 147(11):5259-67. PubMed ID: 16887915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.